Muller WJ - Search Results

1

Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model.

Leslie MA, Abdelmagid SA, Perez K, Muller WJ, Ma DW. Leslie MA, et al. Among authors: muller wj. Lipids Health Dis. 2014 Jun 11;13:96. doi: 10.1186/1476-511X-13-96. Lipids Health Dis. 2014. PMID: 24916956 Free PMC article.

2

Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids.

MacLennan MB, Clarke SE, Perez K, Wood GA, Muller WJ, Kang JX, Ma DW. MacLennan MB, et al. Among authors: muller wj. J Nutr Biochem. 2013 Jan;24(1):388-95. doi: 10.1016/j.jnutbio.2012.08.002. Epub 2012 Sep 29. J Nutr Biochem. 2013. PMID: 23026490

3

Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumors.

Liu J, Abdelmagid SA, Pinelli CJ, Monk JM, Liddle DM, Hillyer LM, Hucik B, Silva A, Subedi S, Wood GA, Robinson LE, Muller WJ, Ma DWL. Liu J, et al. Among authors: muller wj. J Nutr Biochem. 2018 May;55:41-52. doi: 10.1016/j.jnutbio.2017.12.011. Epub 2017 Dec 27. J Nutr Biochem. 2018. PMID: 29413488 Free article.

4

Her-2 Breast Cancer Outcomes Are Mitigated by Consuming n-3 Polyunsaturated, Saturated, and Monounsaturated Fatty Acids Compared to n-6 Polyunsaturated Fatty Acids.

Hillyer LM, Hucik B, Baracuhy EM, Lin Z, Muller WJ, Robinson LE, Ma DWL. Hillyer LM, et al. Among authors: muller wj. Nutrients. 2020 Dec 20;12(12):3901. doi: 10.3390/nu12123901. Nutrients. 2020. PMID: 33419361 Free PMC article.

5

Fish oil supplementation increases expression of mammary tumor apoptosis mediators and reduces inflammation in an obesity-associated HER-2 breast cancer model.

Monk JM, Liddle DM, Hutchinson AL, Burns JL, Wellings H, Cartwright NM, Muller WJ, Power KA, Robinson LE, Ma DWL. Monk JM, et al. Among authors: muller wj. J Nutr Biochem. 2021 Sep;95:108763. doi: 10.1016/j.jnutbio.2021.108763. Epub 2021 Jun 6. J Nutr Biochem. 2021. PMID: 33965532

6

Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis.

Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. Andrechek ER, et al. Among authors: muller wj. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3444-9. doi: 10.1073/pnas.97.7.3444. Proc Natl Acad Sci U S A. 2000. PMID: 10716706 Free PMC article.

7

Mammary gland neoplasia: insights from transgenic mouse models.

Siegel PM, Hardy WR, Muller WJ. Siegel PM, et al. Among authors: muller wj. Bioessays. 2000 Jun;22(6):554-63. doi: 10.1002/(SICI)1521-1878(200006)22:6<554::AID-BIES8>3.0.CO;2-A. Bioessays. 2000. PMID: 10842309 Review.

8

Insights from transgenic mouse models of ERBB2-induced breast cancer.

Ursini-Siegel J, Schade B, Cardiff RD, Muller WJ. Ursini-Siegel J, et al. Among authors: muller wj. Nat Rev Cancer. 2007 May;7(5):389-97. doi: 10.1038/nrc2127. Epub 2007 Apr 19. Nat Rev Cancer. 2007. PMID: 17446858 Review.

9

Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Marcotte R, Muller WJ. Marcotte R, et al. Among authors: muller wj. J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):323-35. doi: 10.1007/s10911-008-9087-3. Epub 2008 Jul 24. J Mammary Gland Biol Neoplasia. 2008. PMID: 18651209 Review.

10

Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer.

Rossdeutscher L, Li J, Luco AL, Fadhil I, Ochietti B, Camirand A, Huang DC, Reinhardt TA, Muller W, Kremer R. Rossdeutscher L, et al. Cancer Prev Res (Phila). 2015 Feb;8(2):120-8. doi: 10.1158/1940-6207.CAPR-14-0110. Epub 2014 Dec 2. Cancer Prev Res (Phila). 2015. PMID: 25468832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page